Voyager Therapeutics Inc. (VYGR)
3.42
0.05 (1.48%)
At close: Apr 02, 2025, 3:59 PM
3.38
-1.17%
After-hours: Apr 02, 2025, 07:55 PM EDT
Voyager Therapeutics Cash Flow Statement
Financials in USD. Fiscal year
is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 |
| Net Income | -65M | 132.33M | -46.41M | -71.2M | 36.74M | -43.6M | -88.29M | -70.7M | -40.19M | -29.67M | -16.32M | -7.67M |
| Depreciation & Amortization | 4.73M | 4.44M | 6.19M | 5.17M | 3.82M | 2.77M | 2.12M | 1.59M | 612K | 600K | 184K | n/a |
| Stock-Based Compensation | 14.79M | 11.15M | 9.34M | 11.32M | 14.93M | 15.64M | 15.71M | 9.24M | 6.31M | 4.03M | 425K | n/a |
| Other Working Capital | -48.84M | 17.64M | 18M | -1.72M | -150.68M | 80.83M | 55.66M | -2.6M | -12.79M | 57.08M | -127K | 182K |
| Other Non-Cash Items | -4.68M | -3.45M | -2.11M | -2.46M | -7.7M | -996K | 1.36M | 674K | 2.94M | 9.75M | 3.31M | 2.03M |
| Deferred Income Tax | n/a | n/a | n/a | 349K | 27K | -3.58M | -2.16M | -24K | 696K | 452K | n/a | n/a |
| Change in Working Capital | 34.86M | -66.56M | 20.47M | 3.29M | -144.54M | 78.44M | 55.38M | -2.13M | -12.85M | 56.14M | 477K | 182K |
| Operating Cash Flow | -15.31M | 77.92M | -12.51M | -53.52M | -96.72M | 48.67M | -15.89M | -61.35M | -42.48M | 41.3M | -11.92M | -5.45M |
| Capital Expenditures | -3.52M | -3.26M | -2.49M | -1.61M | -12.1M | -7.72M | -4.3M | -3.98M | -5.03M | -1.03M | -2.99M | n/a |
| Acquisitions | n/a | 138.39M | 4.85M | -2.46M | -7.7M | 172K | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -465.69M | -223.97M | -54.85M | -15.12M | -70.4M | -494.23M | -333.23M | -147.3M | -112.35M | -220.4M | n/a | n/a |
| Sales Maturities Of Investments | 374.35M | 85.58M | 50M | 82.63M | 195.5M | 411.3M | 364M | 147.6M | 165.1M | 26.66M | n/a | n/a |
| Other Investing Acitivies | n/a | -138.39M | -4.85M | 2.46M | 7.7M | -82.76M | 30.77M | 304K | -421K | -193.74M | -314K | n/a |
| Investing Cash Flow | -94.86M | -141.64M | -7.34M | 65.91M | 113M | -90.48M | 26.47M | -3.68M | 47.3M | -194.77M | -3.3M | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | 19.3M | n/a | 481K | 584K | 844K | n/a | 860K | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 1.24M | 2.52M | 1.11M | 612K | 3.16M | 3.38M | 4.75M | 1.93M | 514K | 72.95M | 22.12M | 5.72M |
| Financial Cash Flow | 114.02M | 33.65M | 1.11M | 612K | 3.16M | 80.99M | 4.75M | 59.92M | 514K | 177.74M | 22.12M | 5.72M |
| Net Cash Flow | 3.85M | -30.08M | -18.74M | 12.99M | 19.44M | 39.18M | 15.33M | -5.11M | 5.33M | 24.27M | 6.9M | 270K |
| Free Cash Flow | -18.83M | 74.66M | -15M | -55.13M | -108.81M | 40.95M | -20.19M | -65.33M | -47.51M | 40.27M | -14.91M | -5.45M |